The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Interface of Candida albicans Biofilm Matrix-Associated Drug Resistance and Cell Wall Integrity Regulation
Open accessAbstract
Candida albicans frequently infects medical devices by growing as a biofilm, i.e., a community of adherent organisms entrenched in an extracellular matrix. During biofilm growth, Candida spp. acquire the ability to resist high concentrations of antifungal drugs. One recently recognized biofilm resistance mechanism involves drug sequestration by matrix β-1,3 glucan. Using a candidate gene approach, we investigated potential C. albicans β-1,3-glucan regulators, based on their homology to Saccharomyces cerevisiae , including SMI1 and protein kinase C (PKC) pathway components. We identified a role for the SMI1 in biofilm matrix glucan production and development of the associated drug resistance phenotype. This pathway appears to act through transcription factor Rlmp and glucan synthase Fks1p. The phenotypes of these mutant biofilms mimicked those of the smi1 Δ/ smi1 Δ biofilm, and overexpression of FKS1 in the smi1 Δ/ smi1 Δ mutant restored the biofilm resistant phenotype. However, control of this pathway is distinct from that of the upstream PKC pathway because the pkc1 Δ/ pkc1 Δ, bck1 Δ/ bck1 Δ, mkk2 Δ/ mkk2 Δ, and mkc1 Δ/ mkc1 Δ biofilms retained the resistant phenotype of the parent strain. In addition, resistance to cell-perturbing agents and gene expression data do not support a significant role for the cell wall integrity pathway during the biofilm formation. Here we show that Smi1p functions in conjunction with Rlm1p and Fks1p to produce drug-sequestering biofilm β-glucan. Our work provides new insight into how the C. albicans biofilm matrix production and drug resistance pathways intersect with the planktonic cell wall integrity pathway. This novel connection helps explain how pathogens in a multicellular biofilm community are protected from anti-infective therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two known transcriptional regulators of biofilm matrix production in C. albicans are Rlm1 and Zap1.”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [136]
In the citing paper
“Deletion of RLM1 causes a reduction in matrix levels (136), whereas deletion of ZAP1 leads to an increase in the accumulation of extracellular matrix material, probably by upregulating the glucoamylases Gca1 and Gca2 (144).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [136]
In the citing paper
“The transcriptional regulator Rlm1 (discussed above) contributes to antifungal drug resistance by regulating the expression of FKS1 (136).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [136]
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Self-citationChandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L., McCormick, T., & Ghannoum, M. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5385-5394.2001 · Cited by 1,578
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance
Mah, T., Pitts, B., Pellock, B. J., Walker, G. C., Stewart, P. S., & O’Toole, G. A. (2003) · Nature · doi:10.1038/nature02122 · Cited by 1,190
Candida Infections of Medical Devices
Kojic, E. M., & Darouiche, R. O. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.255-267.2004 · Cited by 1,055
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815
Rapid Hypothesis Testing with Candida albicans through Gene Disruption with Short Homology Regions
Wilson, R. B., Davis, D. A., & Mitchell, A. P. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.6.1868-1874.1999 · Cited by 763
Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
Ramage, G., Vande Walle, K., Wickes, B. L., & López-Ribot, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2475-2479.2001 · Cited by 753
Flagged first, then by citations
Cited by
Sorted by citations
Sardi, J. C. O., Scorzoni, L., Bernardi, T., Fusco-Almeida, A. M., & Mendes Giannini, M. J. S. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.045054-0 · Cited by 1,184
Candida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Candida albicans biofilms: development, regulation, and molecular mechanisms
Gulati, M., & Nobile, C. J. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.01.002 · Cited by 738
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Development and regulation of single- and multi-species Candida albicans biofilms
Lohse, M. B., Gulati, M., Johnson, A. D., & Nobile, C. J. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.107 · Cited by 643
Ramage, G., Rajendran, R., Sherry, L., & Williams, C. (2012) · International Journal of Microbiology · doi:10.1155/2012/528521 · Cited by 583
Oral Candidiasis: A Disease of Opportunity
Vila, T., Sultan, A. S., Montelongo-Jauregui, D., & Jabra-Rizk, M. A. (2020) · Journal of Fungi · doi:10.3390/jof6010015 · Cited by 537
Campoy, S., & Adrio, J. L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.11.019 · Cited by 511
Pathogenesis ofCandida albicansbiofilm
Tsui, C., Kong, E. F., & Jabra‐Rizk, M. A. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw018 · Cited by 522
Mechanisms of Candida Biofilm Drug Resistance
Taff, H. T., Mitchell, K. F., Edward, J. A., & Andes, D. R. (2013) · Future Microbiology · doi:10.2217/fmb.13.101 · Cited by 422
Self-citationBiofilm of Candida albicans : formation, regulation and resistance
Pereira, R., Fontenelle, R. O. D. S., de Brito, É. H. S., & de Morais, S. M. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14949 · Cited by 417
Candida Species Biofilms’ Antifungal Resistance
Silva, S. M., Rodrigues, C. F., Araújo, D., Rodrigues, M. E., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 317
A Candida Biofilm-Induced Pathway for Matrix Glucan Delivery: Implications for Drug Resistance
Taff, H. T., Nett, J. E., Zarnowski, R., Ross, K. M., Sanchez, H., Cain, M. T., Hamaker, J., Mitchell, A. P., & Andes, D. R. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002848 · Cited by 291
Self-citationCandida albicans biofilms and polymicrobial interactions
Ponde, N. O., Lortal, L., Ramage, G., Naglik, J. R., & Richardson, J. P. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2020.1843400 · Cited by 281
Recent insights into Candida albicans biofilm resistance mechanisms
Mathé, L., & Van Dijck, P. (2013) · Current Genetics · doi:10.1007/s00294-013-0400-3 · Cited by 271
Candida albicans biofilm–induced vesicles confer drug resistance through matrix biogenesis
Zarnowski, R., Sanchez, H., Covelli, A. S., Dominguez, E., Jaromin, A., Bernhardt, J., Mitchell, K. F., Heiss, C., Azadi, P., Mitchell, A., et al. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2006872 · Cited by 260
Self-citationFungal Biofilms, Drug Resistance, and Recurrent Infection
Desai, J. V., Mitchell, A. P., & Andes, D. R. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019729 · Cited by 252
Self-citationBiofilm-Associated Infections: Antibiotic Resistance and Novel Therapeutic Strategies
Sun, F., Qu, F., Yan, L., Mao, P., Xia, P., Chen, H., & Zhou, D. (2013) · Future Microbiology · doi:10.2217/fmb.13.58 · Cited by 221
Mechanistic Understanding of Candida albicans Biofilm Formation and Approaches for Its Inhibition
Atriwal, T., Azeem, K., Husain, F. M., Hussain, A., Khan, M. N., Alajmi, M. F., & Abid, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.638609 · Cited by 222
Polke, M., Hube, B., & Jacobsen, I. D. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2014.12.002 · Cited by 205
Candida and Candidiasis—Opportunism Versus Pathogenicity: A Review of the Virulence Traits
Ciurea, C. N., Kosovski, I.-B., Mare, A. D., Toma, F., Pintea-Simon, I. A., & Man, A. (2020) · Microorganisms · doi:10.3390/microorganisms8060857 · Cited by 210
Update on Antifungal Drug Resistance
Perlin, D. S., Shor, E., & Zhao, Y. (2015) · Current Clinical Microbiology Reports · doi:10.1007/s40588-015-0015-1 · Cited by 181
Contributions of the Biofilm Matrix to Candida Pathogenesis
Nett, J. E., & Andes, D. R. (2020) · Journal of Fungi · doi:10.3390/jof6010021 · Cited by 164
Self-citationThe Interface between Fungal Biofilms and Innate Immunity
Kernien, J. F., Snarr, B. D., Sheppard, D. C., & Nett, J. E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01968 · Cited by 158
Self-citationPortrait of Candida Species Biofilm Regulatory Network Genes
Araújo, D., Henriques, M., & Silva, S. M. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.09.004 · Cited by 140
Candida albicans biofilms: building a heterogeneous, drug-tolerant environment
Bonhomme, J., & d’Enfert, C. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.03.007 · Cited by 120
Pathogenesis and Clinical Relevance of Candida Biofilms in Vulvovaginal Candidiasis
Rodríguez‐Cerdeira, C., Martínez-Herrera, E. O., Carnero-Gregorio, M., López-Bárcenas, A., Fabbrocini, G., Fida, M., El-Samahy, M., & González-Cespón, J. L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.544480 · Cited by 132
Candida albicans Biofilms Do Not Trigger Reactive Oxygen Species and Evade Neutrophil Killing
Xie, Z., Thompson, A. K., Sobue, T., Kashleva, H., Xu, H., Vasilakos, J. P., & Dongari‐Bagtzoglou, A. I. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis607 · Cited by 114
Candida albicans Dispersed Cells Are Developmentally Distinct from Biofilm and Planktonic Cells
Uppuluri, P., Acosta‐Zaldívar, M., Anderson, M. Z., Dunn, M. J., Berman, J. G., Lopez-Ribot, J. L., & Köhler, J. R. (2018) · mBio · doi:10.1128/mbio.01338-18 · Cited by 109
Elucidating Drug Resistance in Human Fungal Pathogens
Xie, J. L., Polvi, E. J., Shekhar‐Guturja, T., & Cowen, L. E. (2014) · Future Microbiology · doi:10.2217/fmb.14.18 · Cited by 103
Kong, E. F., Tsui, C., Kucharíková, S., Dijck, P. V., & Jabra‐Rizk, M. A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01573-17 · Cited by 99
Protein kinase C in fungi—more than just cell wall integrity
Heinisch, J. J., & Rodicio, R. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux051 · Cited by 96
Candida Biofilms: An Update on Developmental Mechanisms and Therapeutic Challenges
de Barros, P. P., Rossoni, R. D., de Souza, C. M., Scorzoni, L., Fenley, J. D. C., & Junqueira, J. C. (2020) · Mycopathologia · doi:10.1007/s11046-020-00445-w · Cited by 106
Candida albicans Biofilm Development and Its Genetic Control
Desai, J. V., & Mitchell, A. P. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0005-2014 · Cited by 94
CandidaBiofilms and the Host: Models and New Concepts for Eradication
Tournu, H., & Dijck, P. V. (2011) · International Journal of Microbiology · doi:10.1155/2012/845352 · Cited by 94
Vila, T. V. M., Kong, E. F., Montelongo‐Jauregui, D., Dijck, P. V., Shetty, A. C., McCracken, C. L., Bruno, V. M., & Jabra‐Rizk, M. A. (2021) · Virulence · doi:10.1080/21505594.2021.1894834 · Cited by 89
The role of Candida albicans stress response pathways in antifungal tolerance and resistance
Iyer, K. R., Robbins, N., & Cowen, L. E. (2022) · iScience · doi:10.1016/j.isci.2022.103953 · Cited by 88
Munro, C. A. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407678-5.00004-0 · Cited by 92
Regulatory Role of Glycerol in Candida albicans Biofilm Formation
Desai, J. V., Bruno, V. M., Ganguly, S., Stamper, R. J., Mitchell, K. F., Solis, N. V., Hill, E. M., Xu, W., Filler, S. G., Andes, D. R., et al. (2013) · mBio · doi:10.1128/mbio.00637-12 · Cited by 86
Self-citationThe Extracellular Matrix of Fungal Biofilms
Mitchell, K. F., Żarnowski, R., & Andes, D. R. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_6 · Cited by 93
Self-citationClinical Implications of Oral Candidiasis: Host Tissue Damage and Disseminated Bacterial Disease
Kong, E. F., Kucharíková, S., Dijck, P. V., Peters, B. M., Shirtliff, M. E., & Jabra‐Rizk, M. A. (2014) · Infection and Immunity · doi:10.1128/iai.02843-14 · Cited by 84
Activity of Sanguinarine against Candida albicans Biofilms
Zhong, H., Hu, D.-D., Hu, G.-H., Su, J., Bi, S., Zhang, Z.-E., Wang, Z., Zhang, R.-L., Xu, Z. Q., Jiang, Y.-Y., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02259-16 · Cited by 81
Candida albicans targets that potentially synergize with fluconazole
Lu, H., Shrivastava, M., Whiteway, M., & Jiang, Y. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1884641 · Cited by 81
Miles, S., Li, L., Davison, J., & Breeden, L. L. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003854 · Cited by 84
Khoury, Z. H., Vila, T. V. M., Puthran, T. R., Sultan, A. S., Montelongo‐Jauregui, D., Melo, M. A. S., & Jabra‐Rizk, M. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00307 · Cited by 84
Visualized Gallium/Lyticase‐Integrated Antifungal Strategy for Fungal Keratitis Treatment
He, J., Ye, Y., Zhang, D., Yao, K., & Zhou, M. (2022) · Advanced Materials · doi:10.1002/adma.202206437 · Cited by 79
Plasticity of Candida albicans Biofilms
Soll, D. R., & Daniels, K. J. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00068-15 · Cited by 86
The Significance of Lipids to Biofilm Formation in Candida albicans: An Emerging Perspective
Alim, D., Sircaik, S., & Panwar, S. L. (2018) · Journal of Fungi · doi:10.3390/jof4040140 · Cited by 78
Participation of Candida albicans Transcription Factor RLM1 in Cell Wall Biogenesis and Virulence
Delgado-Silva, Y., Vaz, C., Carvalho-Pereira, J., Carneiro, C., Nogueira, E., Correia, A., Carreto, L. C., Silva, S. M., Faustino, A., Pais, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086270 · Cited by 79
Effect of Shikonin Against Candida albicans Biofilms
Yan, Y., Tan, F., Hao, M., Wang, H., & Cao, Y. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01085 · Cited by 78
Dominguez, E., Zarnowski, R., Sanchez, H., Covelli, A. S., Westler, W. M., Azadi, P., Nett, J., Mitchell, A. P., & Andes, D. R. (2018) · mBio · doi:10.1128/mbio.00451-18 · Cited by 77
Self-citationEffect of Tetrandrine against Candida albicans Biofilms
Zhao, L., Li, D., Hu, D., Hu, G.-H., Yan, L., Wang, Y., & Jiang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079671 · Cited by 67
Fungal Biofilms: Update on Resistance
Borghi, E., Borgo, F., & Morace, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_7 · Cited by 69
Resistance of Candida albicans Biofilms to Drugs and the Host Immune System
Sandai, D. A., Tabana, Y., Ouweini, A. E., & Ishola, O. A. (2016) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.37385 · Cited by 69
A common vesicle proteome drives fungal biofilm development
Zarnowski, R., Sanchez, H., Jaromin, A., Zarnowska, U. J., Nett, J. E., Mitchell, A. P., & Andes, D. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211424119 · Cited by 63
Self-citationWang, S., Wang, Y., Liu, W., Liu, N., Zhang, Y., Dong, G., Liu, Y., Li, Z., He, X., Miao, Z., et al. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400492t · Cited by 63
The role of antifungals against Candida biofilm in catheter-related candidemia
Bouza, E., Guinea, J., & Guembe, M. (2014) · Antibiotics · doi:10.3390/antibiotics4010001 · Cited by 62
The importance of fungal pathogens and antifungal coatings in medical device infections
Giles, C., Lamont-Friedrich, S. J., Michl, T. D., Griesser, H. J., & Coad, B. R. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.11.010 · Cited by 60
You, J., Du, L., King, J. B., Hall, B. E., & Cichewicz, R. H. (2013) · ACS Chemical Biology · doi:10.1021/cb400009f · Cited by 60
How structured yeast multicellular communities live, age and die?
Váchová, L., & Palková, Z. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy033 · Cited by 58
Monteiro, D. R., Takamiya, A. S., Feresin, L. P., Gorup, L. F., Camargo, E. R., Delbem, A. C. B., Henriques, M., & Barbosa, D. B. (2014) · Journal of Prosthodontic Research · doi:10.1016/j.jpor.2014.07.004 · Cited by 58
The Clinical Importance of Fungal Biofilms
Ramage, G., & Williams, C. (2013) · Advances in applied microbiology · doi:10.1016/b978-0-12-407673-0.00002-3 · Cited by 58
Antifungal drug resistance in Candida: a special emphasis on amphotericin B
Ahmady, L., Gothwal, M., Mukkoli, M. M., & Bari, V. K. (2024) · Apmis · doi:10.1111/apm.13389 · Cited by 61
Dietary Carbohydrates Modulate Candida albicans Biofilm Development on the Denture Surface
Santana, I. L., Gonçalves, L. M., de Vasconcellos, A. A., da Silva, W. J., Cury, J. A., & Cury, A. A. D. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064645 · Cited by 55
Transcriptional Circuits Regulating Developmental Processes in Candida albicans
Rodríguez, D. L., Quail, M. M., Hernday, A. D., & Nobile, C. J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.605711 · Cited by 55
Go Forth and Colonize: Dispersal from Clinically Important Microbial Biofilms
Uppuluri, P., & Lopez-Ribot, J. L. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005397 · Cited by 49
Yeast cell differentiation: Lessons from pathogenic and non-pathogenic yeasts
Palková, Z., & Váchová, L. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.04.006 · Cited by 48
Role of the extracellular matrix in Candida biofilm antifungal resistance
Massey, J., Żarnowski, R., & Andes, D. R. (2023) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuad059 · Cited by 47
Self-citationTrichosporon inkin biofilms produce extracellular proteases and exhibit resistance to antifungals
Cordeiro, R. D. A., Serpa, R., Alexandre, C. F. U., Marques, F. J. D. F., de Melo, C. V. S., Franco, J. D. S., Evangelista, A. J. D. J., Camargo, Z. P. D., Brilhante, R. S. N., Rocha, M. F. G., et al. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000159 · Cited by 45
Lagree, K., & Mitchell, A. P. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.funk-0024-2016 · Cited by 41
Cong, L., Liao, Y., Yang, S., & Yang, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167903 · Cited by 39
Kozák, L., Szilágyi, Z., Tóth, L., Pócsi, I., & Molnár, I. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-09594-x · Cited by 38
Traven, A., Jänicke, A., Harrison, P. F., Swaminathan, A., Seemann, T., & Beilharz, T. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046243 · Cited by 36
Chen, Y., Mauff, F. L., Wang, Y., Lu, R., Sheppard, D. C., Lü, L., & Zhang, S. (2020) · mBio · doi:10.1128/mbio.02329-20 · Cited by 37
Fungal Biofilm Composition and Opportunities in Drug Discovery
Reichhardt, C., Stevens, D. A., & Cegelski, L. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0049 · Cited by 38
Protein Acetylation/Deacetylation: A Potential Strategy for Fungal Infection Control
Chen, J.-Z., Liu, Q., Zeng, L., & Huang, X. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.574736 · Cited by 35
Manfiolli, A. O., dos Reis, T. F., de Assis, L. J., de Castro, P. A., Silva, L. P., Hori, J. I., Walker, L. A., Munro, C. A., Rajendran, R., Ramage, G., et al. (2018) · The Cell Surface · doi:10.1016/j.tcsw.2018.03.002 · Cited by 36
Verma‐Gaur, J., Qu, Y., Harrison, P. F., Lo, T. L., Quenault, T., Dagley, M. J., Belousoff, M. J., Powell, D., Beilharz, T. H., & Traven, A. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005590 · Cited by 33
Candida albicans Biofilms Are Generally Devoid of Persister Cells
Denega, I., d’Enfert, C., & Bachellier-Bassi, S. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01979-18 · Cited by 32
Candida albicans Induces Oral Microbial Dysbiosis and Promotes Oral Diseases
Kashyap, B., Padala, S. R., Kaur, G., & Kullaa, A. M. (2024) · Microorganisms · doi:10.3390/microorganisms12112138 · Cited by 37
Fattouh, N., Hdayed, D., Geukgeuzian, G., Tokajian, S. T., & Khalaf, R. A. (2021) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2021.103575 · Cited by 30
Effects of Hsp90 Inhibitor Ganetespib on Inhibition of Azole-Resistant Candida albicans
Yuan, R., Tu, J., Sheng, C., Chen, X., & Liu, N. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.680382 · Cited by 30
Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis
Sutar, Y. B., Nabeela, S., Singh, S., Alqarihi, A., Solis, N. V., Ghebremariam, T., Filler, S. G., Ibrahim, A. S., Date, A. A., & Uppuluri, P. (2022) · PLoS Biology · doi:10.1371/journal.pbio.3001762 · Cited by 31
Mohammad, H., Elghazawy, N. H., Eldesouky, H. E., Hegazy, Y. A., Younis, W., Avrimova, L., Hazbun, T., Arafa, R. K., & Seleem, M. N. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00215 · Cited by 29
Rodrigues, C. F., & Henriques, M. (2018) · Genes · doi:10.3390/genes9040205 · Cited by 29
Inhibitory effect of novel Eugenol Tosylate Congeners on pathogenicity of Candida albicans
Lone, S. A., & Ahmad, A. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-02929-0 · Cited by 29
Biofilms and oral health: nanotechnology for biofilm control
Govindarajan, D. K., Mohanarangam, M., Kadirvelu, L., Sivaramalingam, S. S., Jothivel, D., Ravichandran, A., Periasamy, S., & Kandaswamy, K. (2025) · Discover Nano · doi:10.1186/s11671-025-04299-3 · Cited by 27
Seddiki, S. M. L., Boucherit-otmani, Boucherit, Badsi-amir, Taleb, & Kunkel (2013) · International Journal of General Medicine · doi:10.2147/ijgm.s38065 · Cited by 27
Haghighi, F., Mohammadi, S. R., Mohammadı, P., Eskandari, M., & Hosseinkhani, S. (2012) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2012_160 · Cited by 25
Management of Candida Biofilms: State Of Knowledge and New Options for Prevention and Eradication
Bujdáková, H. (2016) · Future Microbiology · doi:10.2217/fmb.15.139 · Cited by 27
Inhibitory effect of ficin on Candida albicans biofilm formation and pre-formed biofilms
Yu, J., Wang, F., Shen, Y., Yu, F., Qiu, L., Zhang, L., Chen, Y., Yuan, Q., Zhang, H., Sun, Y., et al. (2022) · BMC Oral Health · doi:10.1186/s12903-022-02384-y · Cited by 25
Jesus, D., de Oliveira, J. R., de Oliveira, F. E., Higa, K. C., Junqueira, J. C., Jorge, A. O. C., Back‐Brito, G. N., & de Oliveira, L. D. (2015) · The Scientific World JOURNAL · doi:10.1155/2015/531972 · Cited by 24
Knr4: a disordered hub protein at the heart of fungal cell wall signalling
Martin‐Yken, H., François, J., & Zerbib, D. (2016) · Cellular Microbiology · doi:10.1111/cmi.12618 · Cited by 25
Jia, C., Zhang, K., Zhang, D., Yu, Q., Zhao, Q., Xiao, C., Dong, Y., Chu, M., & Li, M. (2018) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2018.03.001 · Cited by 22
Da, W., Shao, J., Li, Q., Shi, G., Wang, T., Wu, D., & Wang, C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00034 · Cited by 22
Janeczko, M., Kubiński, K., Martyna, A., Muzyczka, A., Boguszewska‐Czubara, A., Czernik, S., Tokarska-Rodak, M., Chwedczuk, M., Demchuk, O. M., Golczyk, H., et al. (2018) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000700 · Cited by 21
Mechanisms of Azole Potentiation: Insights from Drug Repurposing Approaches
Xiong, J., Lu, H., & Jiang, Y. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c00657 · Cited by 20
Anti-Biofilm Activity of Assamsaponin A, Theasaponin E1, and Theasaponin E2 against Candida albicans
Chen, Y., Gao, Y., Li, Y., & Yin, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073599 · Cited by 21
Curvelo, J. A. D. R., de Moraes, D. C., ANJOS, C. A. D., Portela, M. B., & Soares, R. M. A. (2019) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201920180045 · Cited by 19
Discovery of Piperidol Derivatives for Combinational Treatment of Azole-Resistant Candidiasis
Yang, W., Tu, J., Ji, C., Li, Z., Han, G., Liu, N., Li, J., & Sheng, C. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00849 · Cited by 19
Metadata
- Authors
- Nett, J. E., Sanchez, H., Cain, M. T., Ross, K. M., & Andes, D. R.
- Affiliations
- University of Wisconsin–Madison (US)
- Department of Medicine, University of Wisconsin, Madison, Wisconsin
- Corresponding author
- Andes, David R.
- Venue
- Eukaryotic Cell
- Publisher
- American Society for Microbiology
- Published
- 2011-12
- Volume
- 10
- Issue
- 12
- Pages
- 1660-1669
- ISSN
- 1535-9778 (ISSN-L)
- 1535-9786
- PMC
- PMC3232725
- OpenAlex
- W2138246367
- Cited by
- 168
- References
- 54
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 10 · 2023: 8 · 2022: 13 · 2021: 12 · 2020: 16 · 2019: 8 · 2018: 13 · 2017: 12 · 2016: 17 · 2015: 12 · 2014: 9 · 2013: 17 · 2012: 7
- FWCI
- 7.33
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Eukaryotic Cell (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (T32HL007899)
- National Institute of Allergy and Infectious Diseases (R01AI073289)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Candida albicans, biofilm, antifungal resistance, β-1,3-glucan, extracellular matrix, glucan synthase, protein kinase C pathway, cell wall integrity pathway, drug sequestration, medical device infections, biofilm formation
- MeSH terms
- Animals, Antifungal Agents, Candida albicans, Candidiasis, Cell Wall, Fungal Proteins, Glucosyltransferases, Protein Kinase C, Virulence, Fluconazole, Gene Expression Regulation, Fungal, Biofilms, Drug Resistance, Fungal, beta-Glucans, Mice, Rats, Gene Knockout Techniques, Catheters
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review